Home | Welcome to Contract Pharma   
Last Updated Wednesday, May 27 2015

Print

Search Results for 'biopharma'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published June 5, 2014
Aims to speed drug development Read More »
Can Multivariate Partnerships Streamline Drug Development?
Published June 3, 2014
Quintiles and Biogen Idec enter strategic pact aimed at optimizing Biogen’s clinical development processes Read More »
DPx Holdings, B.V. Three Months Later: A Progress Report With SVP Francisco Negron
Published June 3, 2014
DPx Holdings, B.V. has been moving forward with a new combined OpEx program, and customer-focused projects in Europe Read More »
Walking the Talk at EMD Millipore
Published June 3, 2014
Udit Batra, the company’s President and CEO, brings a knowledge, not only of the lab customer, but the global pharmaceutical consumer, to his new role. Read More »
Will Cell-Based Therapy Shape Biopharma’s Future?
Published June 3, 2014
Pluristem’s CEO, Zami Aberman, compares the state of stem cell research today to where antibodies were 20 years ago. Clinical evidence is key to moving the technology forward, he says. Read More »
Published June 3, 2014
U.S. biopharma has a good image, according to APCO’s latest study, but proactive attention to policymakers and healthcare providers may be helpful Read More »
By Agnes Shanley, Editor
Published June 3, 2014
Good or bad, recurring upheavals and layoffs have become a given. Being prepared is the best defense. Read More »
Working With CRO’s: Lessons for Small Biotechs
By Jean Yarger , ENDECE, LLC
Published June 3, 2014
Outsourcing increases flexibility, but sponsors need a clear strategy, from the start, if they want a synergistic partnership Read More »
Analyzing and Controlling Particles in Biopharmaceuticals
By Tara Sanderson , Formulation Services Manager, SGS
Published June 3, 2014
Patient safety depends on preventing particulate contamination in biopharmaceuticals. Read More »
Improving the Functional Characterization of Biosimilars
By Delana Butz, Ph.D., Manuela Grassi, Ph.D, Onesmo Mpanju, Ph.D., Duu-Gong Wu, Ph.D., Peter Wunderli, Ph.D. , PPD
Published June 3, 2014
New bioassay methods may help reduce the variability of analytical methods required to demonstrate comparability Read More »
Biopharma CMO Update
By William Downey , HighTech Business Decisions
Published June 3, 2014
Increased demand is driving higher capacity utilization and more partnerships Read More »
Published May 29, 2014
To assess the dosing and performance of a subunit antigen vaccine candidate Read More »
Published May 23, 2014
Gains early- and mid-stage assets in major therapeutic categories Read More »
Published May 21, 2014
To supply Ampligen and Alferon N to Latin American market Read More »
Published May 20, 2014
McSorley and Zunggeemoge take on management roles Read More »
Published May 20, 2014
Expands global market access offerings Read More »
Published May 20, 2014
Cunningham brings manufacturing, logistics and supply chain expertise Read More »
Published May 19, 2014
Gains small molecules to potentially cure HBV infections Read More »
Published May 16, 2014
Chaplin brings extensive R&D experience in the field oncology Read More »
Published May 15, 2014
Adds high-throughput screening, drug combination sciences and bioinformatics expertise Read More »
Published May 14, 2014
To offer serum-stable drug-albumin conjugation capability Read More »
Published May 13, 2014
Will provide additional purification and analytical services for Evotec Read More »
Published May 9, 2014
Will combine adaptive trial capabilities with ICON’s technology platforms Read More »
Published May 7, 2014
Andreasson brings extensive biopharma ops experience Read More »
Published May 2, 2014
Will operate Research Models and Contract Research Divisions Read More »
Published May 1, 2014
Forrest brings 25 years of industry experience Read More »
U.S. Biopharm Could Lose 140,000 Jobs by 2024, Study Says
Published May 1, 2014
As global competitiveness increases, U.S. biopharma could lose its edge without different government policies in place, warns a study by Battelle for PhRMA Read More »
By Derek B. Lowe, Contributing Editor
Published May 1, 2014
Most drug companies will only have one successful drug during their lifetimes, and that is probably a good thing. Read More »
Newsmakers: James Foster
By Kristin Brooks, Contract Pharma
Published May 1, 2014
Charles River Labs’ CEO James Foster is looking upstream to offer clients a faster “go/no go” indicator for preclinical work Read More »
It’s a Bird, It’s a Plane...
By Michael Burton , Veeva Systems
Published May 1, 2014
Technology is extending the range of CRO “superheroes” and what they can offer clients. Read More »
Will e-Solutions End the Clinical Paper Chase?
By Mark Wade , Almac
Published May 1, 2014
e-Solutions offer advantages in collecting patient-reported trial outcomes Read More »
Agile Drug Development
By Kristin Brooks , Contract Pharma
Published May 1, 2014
New business models and analytics are driving increased value and efficiency in CRO-sponsor partnerships Read More »
Published April 29, 2014
Gains lead preclinical asset for neurodegenerative diseases Read More »
Published April 28, 2014
Fleming brings more than 25 years of biopharma experience Read More »
Published April 24, 2014
Employs Novozymes' VELTIS technology for optimized dosing Read More »
Published April 22, 2014
De Silva brings 15 years of biopharma experience Read More »
Maik Jornitz on Single-Use Equipment Standardization and Trends
By Kristin Brooks
Published April 15, 2014
Maik Jornitz,COO of G-Con Corporation, who had just chaired a PDA conference track, discusses trends in single-use biopharma processing equipment at Interphex 2014. Read More »
Published April 11, 2014
Frazier and Scangos assume new roles Read More »
Published April 9, 2014
Johnson brings 25 years of experience Read More »
Published April 4, 2014
Will be used to enhance infectious disease development program Read More »
Published April 3, 2014
Kemwell expands lyophilization capacity Read More »
Published April 3, 2014
Catalent, CiRA in regenerative therapy pact Read More »
Published April 3, 2014
AMRI to Acquire Cedarburg Pharma Read More »
Single-Use Equipment Gets Closer to the Patient
By Kristin Brooks , Contract Pharma
Published April 3, 2014
Vaccines and biosimilars, clinical production and cell therapy are driving demand for better control and consistency. Read More »
Injectables CMOs Stay Ahead of Complexity
By Kristin Brooks , Contract Pharma
Published April 3, 2014
Biologics and cytotoxic processes are pushing demand for specialized contract services, especially from small-to-midsized companies. Read More »
Published March 31, 2014
Expands adaptive trial capabilities Read More »
By Kristin Brooks
Published March 28, 2014
Aims to support new regulatory requirements Read More »
Biopharma Trends Drive Equipment Design, Says IPS’ Jeff Odum at Interphex
Published March 27, 2014
IPS Tour Guide Jeff Odum discussed trends now driving bioprocessing equipment, and recapped highlights of his biopharma show floor tour at Interphex 2014. Read More »
By Kristin Brooks
Published March 27, 2014
Spinoff creates independent biopharma and medical products companies Read More »
By Kristin Brooks
Published March 24, 2014
Expands discovery pipeline in multiple sclerosis and CNS Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On